Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 5 Prevalence of Lipid-lowering Medications in Clinic HTG Patients

From: Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study

   Upon Arrival* Clinic Treatment* Latest Visit**
   n (%) n (%) n (%)
Monotherapy: Fibrate 17 (17.9) 54 (56.8) 31 (36.9)
  Statin 16 (16.8) 1 (1.1) 6 (7.1)
  Fish Oil 1 (1.1) 8 (8.4) 3 (3.6)
  Niacin 1 (1.1) 0 2 (2.4)
  Resin 1 (1.1) 0 1 (1.2)
Combination: Fibrate/Statin 4 (4.2) 9 (9.5) 11 (13.1)
  Fibrate/Niacin/Fish Oil 1 (1.1) 1 (1.1) 1 (1.2)
  Fibrate/Fish Oil 1 (1.1) 16 (16.8) 4 (4.8)
  Other 0 2 (2.2) 17 (20.2)
  1. * N = 95, ** N = 84